90Y DOTA/Retinoic Acid
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 90Y DOTA/Retinoic Acid, covering 2016-06-21 to 2016-06-21. Get the full timeline:
Most recent: Clinical Trial Update: 90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET) [Phase 2]